PATENT CLAIM ANALYSIS

Application Number: 15999565
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-08
Patent Classification: ["558", "392000"]

Abstract:
The invention relates to solid pharmaceutical compositions comprising (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4′-trifluoromethylphenyl)-amide, as well as a process for the preparation of the same, methods of using such compositions to treat subjects suffering from autoimmune diseases in particular systemic lupus erythematosus or chronic graft-versus-host disease, multiple sclerosis or rheumatoid arthritis.

Claim (Index 8):
The solid pharmaceutical composition according to  claim 2 , wherein the solid pharmaceutical composition contains no more than about 0.2107% by weight of 2-cyano-N-(4-trifluoromethyl-phenyl)-acetamide after being stored in an open container at about 40\u00b0 C. and about 75% relative humidity for about three months.

Metadata:
- Claim Count in Document: 24.0
- Percentile: 96.0
- Lexical Diversity: 1.20833
- Patent Class: 558.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13422494', '12541410', '13381534', '11238496', '15588304']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6846404173563524
- 35 USC 102 Novelty (BERT): 0.5963283507569266
- Combined Prediction Score: 0.6758092106964098
- Mean Citation Score: 236.55117600000003
- Max Citation Score: 476.25598
- Similarity Product: 392.3690132011128

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test